US.EW · Edwards Lifesciences

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.143111705089653,
        "turnoverUsdM": 253.18984200000003,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.EW",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 85.9414,
      "strength_details": {
        "ma_score": 2,
        "atr_score": 2,
        "rsi_score": 2,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.2,
      "stop_loss_percent": 4.3,
      "take_profit_price": 94.2795,
      "target_multiplier": 1.9,
      "technical_strength": 1.68,
      "take_profit_percent": 5
    },
    "positionPoints": 1.6,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 4.286223410179306,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 65.2,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 62.2,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 3
  },
  "market": {
    "ma20": 89.4245,
    "ma50": 88.9904,
    "close": 89.79,
    "prevClose": 89.83,
    "avgVolume20": 3615190,
    "volumeRatio": 0.78,
    "changePercent": -0.04
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 3,
    "details": {
      "ret_5d": -0.01975982532751075,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 3,
      "vcp_bonus": 0,
      "vol_ratio": 0.7052594325760427,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 0.6733564889208957,
      "volat_points": 0,
      "day_range_pct": 0.017596614322307587,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 65.2,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.7,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 54,
        "contribution": 2.7
      },
      {
        "raw": 13.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 66,
        "contribution": 13.2
      },
      {
        "raw": 10.8,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 72,
        "contribution": 10.8
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.4,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 74,
        "contribution": 7.4
      },
      {
        "raw": 18.1,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 60.33,
        "contribution": 18.1
      },
      {
        "raw": 8,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 80,
        "contribution": 8
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 62.2,
    "details": [
      "基本面分析總分: 2.7/5分",
      "資金流分析總分: 13.2/20分",
      "市場環境分析總分: 10.8/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.4/10分",
      "技術信號分析總分: 18.1/30分",
      "情緒分析: 8/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.7,
      "資金流": 13.2,
      "市場環境": 10.8,
      "情緒分析": 8,
      "技術信號": 18.1,
      "風險管理": 7.4
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0.4,
          "turnoverUsdM": 253.18984200000003,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "一般",
        "items": {
          "cmfPoints": 2.4,
          "mfiPoints": 3.2,
          "obvPoints": 1.6,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.EW",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "良好",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 16.01
            }
          },
          "trend": {
            "score": 3,
            "details": {
              "qqq": {
                "ma20": 709.1885013500001,
                "ma50": 713.4416018399997,
                "name": "QQQ",
                "close": 713.44,
                "points": 1
              },
              "spy": {
                "ma20": 762.32700215,
                "ma50": 751.7496043999998,
                "name": "SPY",
                "close": 765.71997,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.143111705089653,
          "atrPoints": 3,
          "cciPoints": 2.4,
          "vixPoints": 2.4,
          "marketTrendPoints": 3
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "優秀",
        "items": {
          "sentiment": {
            "score": 8,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 6,
              "sentimentScoreRaw": 1.8
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141281699,
                "url": "https://finnhub.io/api/news?id=fbaa0fb465cb7b5e94846908c161eb264c0d032f7d5847c1fe48539bec4bf65b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences (EW) recently held its annual Asia Pacific Patient Experience event, spotlighting patient and caregiver perspectives on structural heart disease. For investors, the gathering raises questions about how patient engagement connects to Edwards Lifesciences stock. See our latest analysis for Edwards Lifesciences. At a share price of $89.83, Edwards Lifesciences has seen a 6.24% 30 day share price return and a 4.72% 90 day share price return, while the 1 year total shareholder...",
                "category": "company",
                "datetime": 1787271133,
                "headline": "Is Edwards Lifesciences (EW) A Bargain Following Its Asia Pacific Patient Experience Event?"
              },
              {
                "id": 141281712,
                "url": "https://finnhub.io/api/news?id=7cbf6a4bd23762f011394fe6ea8002bc11c79ee562a732acfa1f89a8c4684880",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences stock has delivered a 21.6% gain over the past three years, yet the valuation checks paint a less generous picture. The intrinsic value estimate from a Discounted Cash Flow (DCF) model indicates the shares are roughly fairly valued, while traditional market multiples lean expensive. Over the last three years, Edwards Lifesciences has returned 21.6%, which rewards patient holders but leaves fresh buyers needing to judge how much upside is left at today’s...",
                "category": "company",
                "datetime": 1787213454,
                "headline": "Edwards Lifesciences (EW) Stock Could Be 1% Above Fair Value On Cash Flow And Earnings"
              },
              {
                "id": 141226765,
                "url": "https://finnhub.io/api/news?id=944238222c9a941c04cbf9bb360c8aaf00f754e3da0e49ccc10edebf065198f3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences pairs accelerating structural heart growth and stronger leverage with a premium valuation that leaves less room for execution setbacks.",
                "category": "company",
                "datetime": 1786725420,
                "headline": "Is EW Stock Worth Buying as Growth Clashes With a Premium Valuation?"
              },
              {
                "id": 141110261,
                "url": "https://finnhub.io/api/news?id=4115d1e3ced7ffc938f7e11b62364d19c915c9f89f2113ea724850dd066e3538",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Baron Capital, an investment management company, released its Q2 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here. The Fund gained 11.99% during the quarter, compared with the 10.48% gain for the Russell 3000 Health Care Index and the 15.44% gain for the Russell 3000 Index. Since inception, […]",
                "category": "company",
                "datetime": 1785856652,
                "headline": "Edwards Lifesciences (EW) Has a Growth Runway Competitors May Struggle to Match"
              },
              {
                "id": 141037316,
                "url": "https://finnhub.io/api/news?id=20190819d5293f8bb8dc1b1f77910f7a4721d08607b709d03904590042fdd75f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "On July 23, Edwards Lifesciences Corporation (NYSE:EW) delivered second-quarter 2026 net sales of $1.74 billion, up 13.6% year over year (12.5% on a constant currency basis), surpassing Wall Street expectations of $1.70 billion. Adjusted diluted earnings per share came in at $0.78, ahead of the consensus estimate of $0.74 and up 16.4% from $0.67 a […]",
                "category": "company",
                "datetime": 1785183627,
                "headline": "Edwards Lifesciences (EW)’s TMTT Revenue Surges 47%: Can Rapid Growth Drive the Next Leg of Earnings Expansion?"
              },
              {
                "id": 141016117,
                "url": "https://finnhub.io/api/news?id=c3025646096062355f708ef9b445ef39446ddbc9439e0796a71dc0983a28989f",
                "image": "",
                "source": "Fintel",
                "related": "EW",
                "summary": "",
                "category": "company",
                "datetime": 1784984157,
                "headline": "Leerink Partners Upgrades Edwards Lifesciences (EW)"
              },
              {
                "id": 141014148,
                "url": "https://finnhub.io/api/news?id=c78de666c8ec263549d7c2acf32328d18d87b576b14ef340657b7e52347ddff6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences stock sits at an interesting spot for valuation focused investors, with the Discounted Cash Flow (DCF) based intrinsic value estimate suggesting the shares are roughly in line with underlying cash flow assumptions, while the broader checks still point to a stock that does not screen as cheap and has delivered a decline over five years. Over the past 5 years, Edwards Lifesciences has delivered a total return that is down 26.4%, which raises the question of whether the...",
                "category": "company",
                "datetime": 1784956267,
                "headline": "Edwards Lifesciences (EW) Stock Looks Fair On Cash Flow While Earnings Trade At A Premium"
              },
              {
                "id": 141002771,
                "url": "https://finnhub.io/api/news?id=5e742edd1cfd6865d6cf619e68b6ba9dde8febc21f2134a81974aa461f25fde4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences Corp (EW) reports a robust 12.5% sales increase, driven by innovation and strategic growth across key segments.",
                "category": "company",
                "datetime": 1784869255,
                "headline": "Edwards Lifesciences Corp (EW) Q2 2026 Earnings Call Highlights: Strong Sales Growth and ..."
              }
            ],
            "raw_source": [
              {
                "id": 141279655,
                "url": "https://finnhub.io/api/news?id=4022a61f18744248d075fbe3cc8738debb8f01b33118af64b4cac3ad000ade69",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "STE is betting $600 million on a new chemistry center to boost capacity and efficiency, but higher spending and execution risks loom.",
                "category": "company",
                "datetime": 1787331660,
                "headline": "Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?"
              },
              {
                "id": 141281699,
                "url": "https://finnhub.io/api/news?id=fbaa0fb465cb7b5e94846908c161eb264c0d032f7d5847c1fe48539bec4bf65b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences (EW) recently held its annual Asia Pacific Patient Experience event, spotlighting patient and caregiver perspectives on structural heart disease. For investors, the gathering raises questions about how patient engagement connects to Edwards Lifesciences stock. See our latest analysis for Edwards Lifesciences. At a share price of $89.83, Edwards Lifesciences has seen a 6.24% 30 day share price return and a 4.72% 90 day share price return, while the 1 year total shareholder...",
                "category": "company",
                "datetime": 1787271133,
                "headline": "Is Edwards Lifesciences (EW) A Bargain Following Its Asia Pacific Patient Experience Event?"
              },
              {
                "id": 141279658,
                "url": "https://finnhub.io/api/news?id=ccdd2318d04922d45cc700e03560485e831e0d06bfb5bd3eddc8df398c53b11c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "STE enters fiscal 2027 with solid growth, recurring healthcare demand and better margins, but tariffs and investment needs temper the valuation case.",
                "category": "company",
                "datetime": 1787240760,
                "headline": "Should Investors Buy STERIS as Growth Meets Reasonable Valuation?"
              },
              {
                "id": 141281711,
                "url": "https://finnhub.io/api/news?id=33fb2f7d230305748eb64361fcd64ac85f4c63044989f61841a0253cd5a060e9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "EW's TAVR and TMTT growth support its outlook, but currency pressure and intense competition remain key risks.",
                "category": "company",
                "datetime": 1787240640,
                "headline": "Should You Hold Edwards Lifesciences Stock in Your Portfolio?"
              },
              {
                "id": 141281712,
                "url": "https://finnhub.io/api/news?id=7cbf6a4bd23762f011394fe6ea8002bc11c79ee562a732acfa1f89a8c4684880",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences stock has delivered a 21.6% gain over the past three years, yet the valuation checks paint a less generous picture. The intrinsic value estimate from a Discounted Cash Flow (DCF) model indicates the shares are roughly fairly valued, while traditional market multiples lean expensive. Over the last three years, Edwards Lifesciences has returned 21.6%, which rewards patient holders but leaves fresh buyers needing to judge how much upside is left at today’s...",
                "category": "company",
                "datetime": 1787213454,
                "headline": "Edwards Lifesciences (EW) Stock Could Be 1% Above Fair Value On Cash Flow And Earnings"
              },
              {
                "id": 141257577,
                "url": "https://finnhub.io/api/news?id=59a8c98036ebd53aa47d15b1c10d92f5707d3dbbb713613742e196709dbde0eb",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "EW",
                "summary": "Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 20 years by 7.93% on an annualized basis producing an average annual return of 17.22%. Currently, Edwards Lifesciences has a market capitalization",
                "category": "company",
                "datetime": 1787140833,
                "headline": "Here’s How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 20 Years"
              },
              {
                "id": 141265012,
                "url": "https://finnhub.io/api/news?id=6306299bf8c0083ad7ed7398a1dda29d79bf659716d1cdeed57bf18c43632e5c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Pentavere advances from winning the 2024 Prix Galien USA Award to competing internationally among Prix Galien winners from around the world, further validating DARWEN™ AI as a globally recognized healthcare AI platformThe broader 2026 International Prix Galien nominee field includes innovations from many of the world's leading pharmaceutical, biotechnology and medical technology companies, including AstraZeneca, Merck & Co. (MSD), Johnson & Johnson, Pfizer, Sanofi, Regeneron, Roche, Novo...",
                "category": "company",
                "datetime": 1787139000,
                "headline": "HEALWELL AI's DARWEN(TM) AI Platform Nominated for 2026 International Prix Galien, the Global \"Best of the Best\" in Life Sciences Innovation"
              },
              {
                "id": 141281702,
                "url": "https://finnhub.io/api/news?id=9ee0f935c15acfa81f3ddf768978842481802bbaccf219995d7b80d62e8f8366",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "As structural heart disease continues to impact a growing number of people across Asia Pacific amid a rapidly ageing population, Edwards Lifesciences (Edwards) brought together patients for its annual Asia-Pacific Patient Experience event. The programme created a platform for patients, caregivers, healthcare professionals and employees to share perspectives, foster meaningful connections and deepen understanding of the patient journey.",
                "category": "company",
                "datetime": 1787133600,
                "headline": "Putting Patients at the Heart of Innovation: Voices Across Asia Pacific Help Shape the Future of Structural Heart Care"
              },
              {
                "id": 141251970,
                "url": "https://finnhub.io/api/news?id=4364ba6127479c07f5699a16fac7cbec7765cc2acfb197a9f0960759f80cbeac",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Gary Sorsher has been named executive vice president and chief quality officer, effective September 8.",
                "category": "company",
                "datetime": 1787002200,
                "headline": "BD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to Retire"
              },
              {
                "id": 141226765,
                "url": "https://finnhub.io/api/news?id=944238222c9a941c04cbf9bb360c8aaf00f754e3da0e49ccc10edebf065198f3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences pairs accelerating structural heart growth and stronger leverage with a premium valuation that leaves less room for execution setbacks.",
                "category": "company",
                "datetime": 1786725420,
                "headline": "Is EW Stock Worth Buying as Growth Clashes With a Premium Valuation?"
              },
              {
                "id": 141219196,
                "url": "https://finnhub.io/api/news?id=d589796c49ee8c58aad29f907397207bc3d2821e4436174cdabb2cfa8eb12a60",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "EW",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often",
                "category": "company",
                "datetime": 1786714524,
                "headline": "9 Health Care Stocks Whale Activity In Today’s Session"
              },
              {
                "id": 141216725,
                "url": "https://finnhub.io/api/news?id=75b3ea82141ce5c2d9b288a912788b857b5a70b3f29d76f59065d6a21564acbb",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1282122168/image_1282122168.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "EW",
                "summary": "Boston Scientific (BSX) stock: EP/WATCHMAN slowdown drives discount valuation. See why it’s a Buy—new launches, insider buying, cost savings.",
                "category": "company",
                "datetime": 1786705872,
                "headline": "Boston Scientific: A Deep Dive Into The Headwinds And Why I See A Recovery Ahead"
              },
              {
                "id": 141220590,
                "url": "https://finnhub.io/api/news?id=6ee2ff0112658e580c4563d0a8c6ffbb026313e5cc042f656138199849bc8dc6",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "EW",
                "summary": "Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 15 years by 1.31% on an annualized basis producing an average annual return of 15.06%. Currently, Edwards Lifesciences has a market capitalization",
                "category": "company",
                "datetime": 1786643145,
                "headline": "$100 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth This Much Today"
              },
              {
                "id": 141205611,
                "url": "https://finnhub.io/api/news?id=dd5eca2ade8f4181ead20a9e255e7c1a5afce1573708bd3d80f4816f41e5a7fe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards' 14% three-month rally reflects broad structural-heart growth, but its premium valuation raises the bar for execution.",
                "category": "company",
                "datetime": 1786625460,
                "headline": "Edwards Climbs 14% in 3 Months as Growth Strength Tests Valuation"
              },
              {
                "id": 141202085,
                "url": "https://finnhub.io/api/news?id=8688db89e262b9bd5d93cb3731e971b1f24a8c364cc2fc621a4f9c938d2f806a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Though Edwards Lifesciences has underperformed the broader market over the past year, Wall Street analysts maintain a strongly optimistic outlook on the stock’s prospects.",
                "category": "company",
                "datetime": 1786539674,
                "headline": "Is Wall Street Bullish or Bearish on Edwards Lifesciences Stock?"
              },
              {
                "id": 141192888,
                "url": "https://finnhub.io/api/news?id=8bfe3da79a9d72b2c4f660fa91d74daddc52a60efc7a41079b049140729b94ef",
                "image": "",
                "source": "SeekingAlpha",
                "related": "EW",
                "summary": "",
                "category": "company",
                "datetime": 1786528125,
                "headline": "Edwards Lifesciences: Strong Execution, But Little Room For Error At $90"
              },
              {
                "id": 141191790,
                "url": "https://finnhub.io/api/news?id=3b4a18b4d28df314a1c8e3ba7b6ed1d79058f97d4fb702b12e7d1f1b737ab971",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1182459087/image_1182459087.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "EW",
                "summary": "Edwards Lifesciences' Q2 saw 13.6% YoY sales growth, but Q3 guidance implies a sequential decline attributed to tough comps, not demand. Read more on EW stock here.",
                "category": "company",
                "datetime": 1786506905,
                "headline": "Edwards Lifesciences: Cheap Against Itself, Expensive Against Everything Else"
              },
              {
                "id": 141137293,
                "url": "https://finnhub.io/api/news?id=262782447449ff61a7c3702f9cf92ea2613dbee793882d07196dcd81e31db6ba",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Intuitive Surgical's da Vinci 5 is gaining rapid adoption, fueling hospital upgrades as software enhancements build a potential multi-year capital cycle.",
                "category": "company",
                "datetime": 1786030860,
                "headline": "Can da Vinci 5 Drive Intuitive Surgical's Next Multi-Year Upgrade Cycle?"
              },
              {
                "id": 141138529,
                "url": "https://finnhub.io/api/news?id=3d6adcd10fcf2ffa79d180e9fc6d7fcd0af2335aa79abdac4e9592049ff9afa5",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2256895141/image_2256895141.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "EW",
                "summary": "For the second quarter of 2026, Aristotle Capital’s Value Equity WM Composite posted a total return of 4.36% pure gross of fees (3.85% net of fees). Read more here.",
                "category": "company",
                "datetime": 1786030140,
                "headline": "Aristotle Value Equity WM Q2 2026 Portfolio Performance"
              },
              {
                "id": 141110261,
                "url": "https://finnhub.io/api/news?id=4115d1e3ced7ffc938f7e11b62364d19c915c9f89f2113ea724850dd066e3538",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Baron Capital, an investment management company, released its Q2 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here. The Fund gained 11.99% during the quarter, compared with the 10.48% gain for the Russell 3000 Health Care Index and the 15.44% gain for the Russell 3000 Index. Since inception, […]",
                "category": "company",
                "datetime": 1785856652,
                "headline": "Edwards Lifesciences (EW) Has a Growth Runway Competitors May Struggle to Match"
              },
              {
                "id": 141067090,
                "url": "https://finnhub.io/api/news?id=aa2720d6e7ac7468a04319a21c33a925100f21fbffe6af756accd270771884a5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Investors need to pay close attention to EW stock based on the movements in the options market lately.",
                "category": "company",
                "datetime": 1785421980,
                "headline": "Is the Options Market Predicting a Spike in Edwards Lifesciences Stock?"
              },
              {
                "id": 141054180,
                "url": "https://finnhub.io/api/news?id=173d1471a0afe80e918828513f087fc2f78dca076daaffafbb0fcb8a6366ef3e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Facing competition from Edwards, Abbott is studying TriClip’s real-world safety and performance in about 1,000 patients.",
                "category": "company",
                "datetime": 1785319200,
                "headline": "Abbott starts TriClip study amid rising competition for heart valve repair"
              },
              {
                "id": 141042644,
                "url": "https://finnhub.io/api/news?id=7507ca35b1cbe8e76ab6c5b9c089fdd29418dcb58a04e57f6822f7749625c588",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1785245664,
                "headline": "Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls"
              },
              {
                "id": 141040714,
                "url": "https://finnhub.io/api/news?id=c0dcf572278a87fdc5bdf02ed6d81b218534ccffed862d9b68a0f1bba5309517",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "DUBLIN, July 28, 2026--CroíValve, a clinical-stage medical device company developing the DUO™ transcatheter tricuspid coaptation valve system, today announced the appointment of Jaime Wheeler, MBA, CPhT, as Chief Executive Officer. In conjunction with this, Lucy O’Keeffe will transition into the role of Chief Operating Officer where she will support Jaime in delivering CroíValve’s mission of innovating a better way to treat tricuspid regurgitation (TR). Jaime is a transformational healthcare exe",
                "category": "company",
                "datetime": 1785223800,
                "headline": "CroíValve Announces the Appointment of Jaime Wheeler as Chief Executive Officer"
              },
              {
                "id": 141037316,
                "url": "https://finnhub.io/api/news?id=20190819d5293f8bb8dc1b1f77910f7a4721d08607b709d03904590042fdd75f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "On July 23, Edwards Lifesciences Corporation (NYSE:EW) delivered second-quarter 2026 net sales of $1.74 billion, up 13.6% year over year (12.5% on a constant currency basis), surpassing Wall Street expectations of $1.70 billion. Adjusted diluted earnings per share came in at $0.78, ahead of the consensus estimate of $0.74 and up 16.4% from $0.67 a […]",
                "category": "company",
                "datetime": 1785183627,
                "headline": "Edwards Lifesciences (EW)’s TMTT Revenue Surges 47%: Can Rapid Growth Drive the Next Leg of Earnings Expansion?"
              },
              {
                "id": 141016117,
                "url": "https://finnhub.io/api/news?id=c3025646096062355f708ef9b445ef39446ddbc9439e0796a71dc0983a28989f",
                "image": "",
                "source": "Fintel",
                "related": "EW",
                "summary": "",
                "category": "company",
                "datetime": 1784984157,
                "headline": "Leerink Partners Upgrades Edwards Lifesciences (EW)"
              },
              {
                "id": 141014148,
                "url": "https://finnhub.io/api/news?id=c78de666c8ec263549d7c2acf32328d18d87b576b14ef340657b7e52347ddff6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences stock sits at an interesting spot for valuation focused investors, with the Discounted Cash Flow (DCF) based intrinsic value estimate suggesting the shares are roughly in line with underlying cash flow assumptions, while the broader checks still point to a stock that does not screen as cheap and has delivered a decline over five years. Over the past 5 years, Edwards Lifesciences has delivered a total return that is down 26.4%, which raises the question of whether the...",
                "category": "company",
                "datetime": 1784956267,
                "headline": "Edwards Lifesciences (EW) Stock Looks Fair On Cash Flow While Earnings Trade At A Premium"
              },
              {
                "id": 141005872,
                "url": "https://finnhub.io/api/news?id=74fe11d832993c0a9ab47eef2a14c7c38da71f7011ef32455844d38d129c56ab",
                "image": "https://www.chartmill.com/images/uploads/CM_Gap_Stocks_Small_free_ad767b11cf.webp",
                "source": "ChartMill",
                "related": "EW",
                "summary": "Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Friday. Discover the gap up and gap down stocks in the S&P500 index.",
                "category": "company",
                "datetime": 1784903701,
                "headline": "Friday's session: gap up and gap down stock in the S&P500 index"
              },
              {
                "id": 141006595,
                "url": "https://finnhub.io/api/news?id=37c5f3d4f6cf608cf606099c2250e66aa4c45e9928fe2dfee311c50b74f9ce74",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences stock launched higher Friday after the medtech company beat Wall Street's top- and bottom-line expectations.",
                "category": "company",
                "datetime": 1784903038,
                "headline": "Edwards, The 'Cleanest Large-Cap Medtech Story,' Launches On Second-Quarter Beat"
              },
              {
                "id": 141008589,
                "url": "https://finnhub.io/api/news?id=90adc2bfc27e86084efb037010c27e173264ef197937243fdcee8ddb947bc636",
                "image": "",
                "source": "Benzinga",
                "related": "EW",
                "summary": "JP Morgan  analyst Robbie Marcus   maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $100 to $105.",
                "category": "company",
                "datetime": 1784900766,
                "headline": "JP Morgan Maintains Overweight on Edwards Lifesciences, Raises Price Target to $105"
              },
              {
                "id": 141005405,
                "url": "https://finnhub.io/api/news?id=70bfa83ccbba1d01ee7ccb7f4e996315592255d14809a1f1e015ac69caced29b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "SpaceX initiated, PayPal upgraded: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1784899968,
                "headline": "SpaceX initiated, PayPal upgraded: Wall Street's top analyst calls"
              },
              {
                "id": 141005473,
                "url": "https://finnhub.io/api/news?id=7e5c1ee50c7bd031d2b9de1613cc78cef1c03319d1995635d0efc1439e84fa19",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards TAVR business contributed the lion’s share of its Q2 revenues at $1.26bn, largely informing its decision to uplift its 2026 revenue growth outlook.",
                "category": "company",
                "datetime": 1784899135,
                "headline": "Edwards lifts FY26 growth outlook following steady Q2 performance"
              },
              {
                "id": 141006524,
                "url": "https://finnhub.io/api/news?id=32051c07b4e7a4e0c1418e8e01970f2ac0db8656ab65fcebe5b9d5274caa4129",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "EW beats Q2 earnings and revenue estimates as strong TAVR demand, and mitral and tricuspid therapy adoption lift results and guidance.",
                "category": "company",
                "datetime": 1784897640,
                "headline": "Edwards' Q2 Earnings & Revenues Top Estimates, Stock Rises"
              },
              {
                "id": 141008590,
                "url": "https://finnhub.io/api/news?id=423ca23e4ad3509ce029759ad75854628ba77b80c037b50fb1f815ead64a96e2",
                "image": "",
                "source": "Benzinga",
                "related": "EW",
                "summary": "Piper Sandler  analyst Adam Maeder   reiterates Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $100 to $101.",
                "category": "company",
                "datetime": 1784896678,
                "headline": "Piper Sandler Reiterates Overweight on Edwards Lifesciences, Raises Price Target to $101"
              },
              {
                "id": 141004719,
                "url": "https://finnhub.io/api/news?id=ab72008a4b23c5002a67cdd879c5165c836f6ad4e946cb7eaf13fce827bc33f2",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "EW",
                "summary": "As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the S&P500 stocks leading the pack in terms of gains and losses.",
                "category": "company",
                "datetime": 1784896500,
                "headline": "These S&P500 stocks are moving in today's pre-market session"
              },
              {
                "id": 141016332,
                "url": "https://finnhub.io/api/news?id=25f374e33cec0eb53c275bea4d9bd66481a25b48a7153304586f183620521c1c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Moby summary of Edwards Lifesciences Corporation's Q2 2026 earnings call",
                "category": "company",
                "datetime": 1784896200,
                "headline": "Edwards Lifesciences Corporation Q2 2026 Earnings Call Summary"
              },
              {
                "id": 141008591,
                "url": "https://finnhub.io/api/news?id=7a82389b504b8ccc03147bb02d1992bb5df2759106591c3310e2847917101868",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/24/Irvine--California---7-May-2023-Edwards-.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "EW",
                "summary": "Edwards Lifesciences tops Q2 Wall Street estimates with $1.74B in revenue. EW stock jumps as analysts see continued upside ahead.",
                "category": "company",
                "datetime": 1784893695,
                "headline": "Edwards Earnings Add Fuel To Bullish MedTech Thesis, Analyst Says"
              },
              {
                "id": 141008029,
                "url": "https://finnhub.io/api/news?id=b2424bef56873a8554028ac6ef1baac437d1a795399281013938d4c76246c938",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "An upcoming Medicare coverage decision for transcatheter aortic valve replacement devices and study readout for patients with moderate disease are expected to help the company maintain its momentum.",
                "category": "company",
                "datetime": 1784892392,
                "headline": "Edwards posts strong TAVR sales ahead of potential Medicare coverage expansion"
              },
              {
                "id": 141005802,
                "url": "https://finnhub.io/api/news?id=a70b07018e3a368ce5ffe7fc9eba41d0c1a04a50606c7c0079ca0c378506ec56",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/24/Wall-Street.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "EW",
                "summary": "U.S. stock futures were higher on Friday, as the Dow Jones, S&P 500 and Nasdaq 100 indices rose, following Thursday's lower close.",
                "category": "company",
                "datetime": 1784883752,
                "headline": "Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Gain as Oil Prices Decline—Intel, Edwards Lifesciences, SAP in Focus (UPDATED)"
              },
              {
                "id": 141002771,
                "url": "https://finnhub.io/api/news?id=5e742edd1cfd6865d6cf619e68b6ba9dde8febc21f2134a81974aa461f25fde4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences Corp (EW) reports a robust 12.5% sales increase, driven by innovation and strategic growth across key segments.",
                "category": "company",
                "datetime": 1784869255,
                "headline": "Edwards Lifesciences Corp (EW) Q2 2026 Earnings Call Highlights: Strong Sales Growth and ..."
              },
              {
                "id": 141008337,
                "url": "https://finnhub.io/api/news?id=9dd6072c4dff5a6fc4f9f7ef11ba6af85796b34185b3d5d9fb06ba505bccf295",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/24/American-Express-Platinum-amex-Platinum-.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "EW",
                "summary": "US stock futures mixed, focus on companies like American Express, Deckers, Verizon, Edwards Lifesciences, and HCA Healthcare for today's trading.",
                "category": "company",
                "datetime": 1784859381,
                "headline": "American Express, Deckers Outdoor And 3 Stocks To Watch Heading Into Friday"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 6,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.8,
            "source_article_count": 41,
            "discarded_article_count": 33
          },
          "sentimentPoints": 8
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 18.1,
        "grade": "一般",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 1.8,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1.8,
            "vcp_reason": "量縮(v10/v30=0.66)；跌縮量(近10日5日)；站上MA50；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 4,
              "vol_ref": 4398846.666666667,
              "down_days": 5,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 2908410,
              "avg_vol_20": 3998245,
              "avg_vol_30": 4398846.666666667,
              "range_pct_10": 0.05902661766343687,
              "range_pct_20": 0.14199799532241897,
              "range_pct_30": 0.14199799532241897,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.6611755808719558,
              "dist_to_20d_high": 0.04387179214141189,
              "down_shrink_days": 5,
              "breakout_level_20d": 93.91,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.41568627450980367
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 2.4,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.143111705089653,
              "turnoverUsdM": 253.18984200000003,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.EW",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 85.9414,
            "strength_details": {
              "ma_score": 2,
              "atr_score": 2,
              "rsi_score": 2,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.2,
            "stop_loss_percent": 4.3,
            "take_profit_price": 94.2795,
            "target_multiplier": 1.9,
            "technical_strength": 1.68,
            "take_profit_percent": 5
          },
          "positionPoints": 1.6,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 4.286223410179306,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 100,
    "atr": {
      "atr": 1.9243,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.14
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "平衡",
      "score": 6,
      "value": 9.83
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "輕微流入",
      "score": 6,
      "value": 0.1815
    },
    "kdj": {
      "d": 55.85,
      "j": 9.43,
      "k": 40.38,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "入貨中",
      "score": 8,
      "value": 63.5
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 4,
      "trend": "弱勢",
      "value": 4100,
      "recentSlope": -640380,
      "previousSlope": 2534150
    },
    "rsi": 53.76,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 93.8268,
      "position": "SAR喺價上",
      "distancePct": 4.5,
      "previousTrend": "下降"
    },
    "ma50": 88.9904,
    "macd": {
      "macd": 0.8505466812134728,
      "trend": "中性偏多",
      "signal": 0.8680103142077682,
      "histogram": -0.01746363299429543
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 88.5052,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 15
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.78,
      "score": 2,
      "avgVolume": 3615190,
      "currentVolume": 2819800
    },
    "derived": {
      "ma20": 89.4245,
      "ma50": 88.9904,
      "prevClose": 89.83,
      "avgVolume10": 2946190,
      "avgVolume20": 3615190,
      "changePercent": -0.04,
      "avgVolumeForScore": 3615190
    },
    "ma_cross": {
      "ma20": 89.4245,
      "ma50": 88.9904,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "接近",
      "score": 6,
      "prevMa20": 89.0665,
      "prevMa50": 88.9142,
      "spreadPct": 0.49,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 83.5825,
      "upper": 95.2665,
      "position": "上半部"
    },
    "rsi_short": 25.74,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.78
    }
  }
}

{
  "close": 89.79,
  "volume": 2819800,
  "changePercent": -0.04
}